The Chemours CompanyCCNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank0
3Y CAGR-46.7%
5Y CAGR-25.1%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-46.7%/yr
vs -6.2%/yr prior
5Y CAGR
-25.1%/yr
Recent deceleration
Acceleration
-40.5pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$181.00M-73.8%
2024$692.00M+251.3%
2023$197.00M-83.5%
2022$1.20B+1.4%
2021$1.18B+53.6%
2020$767.00M+7.3%
2019$715.00M-53.7%
2018$1.54B+14.7%
2017$1.34B+88.1%
2016$715.00M-